• June 3-6, 2024
  • San Diego Convention Center, California

Speakers

Loading
John Mohr

John Mohr, PharmD

SVP, Clinical Development and Medical Affairs
scPharmaceuticals
Dr. Mohr is a pharmacist with 20 years of experience as a clinician, researcher, teacher, scientist and medical affairs leader. Dr. Mohr began his career in the pharmaceutical industry at Cubist Pharmaceuticals within the Medical Affairs function. In addition, he supported the medical affairs integration of two companies (Adalor and Optimer) upon acquisition and led the medical affairs launch of Zerbaxa and Sivextro until Cubist was acquired by Merck for $9.5 billion. Following his tenure at Cubist Pharmaceuticals, John served as Vice President of Medical Affairs at the Medicines Company where he led the medical affairs strategy for Orbactiv and Minocin IV, and as Vice President of Medical Affairs at Tetraphase, where he managed building out the medical affairs function to support the launch of Xerava. Dr. Mohr received his B.S. in Biomedical Sciences from Texas A&M University and his Pharm.D. from the University of Houston College of Pharmacy.

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS